INDV (Indivior Pharmaceuticals, Inc. Common Stock) Stock Analysis - Financials
Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of May 20, 2026, INDV trades at $38.04 with a market cap of $4.32B and a P/E ratio of 22.16. INDV moved +2.91% today. Year to date, INDV is +3.53%; over the trailing twelve months it is +216.69%. Its 52-week range spans $7.33 to $41.00. Analyst consensus is strong buy with an average price target of $50.67. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are INDV's key financials?
INDV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INDV recently traded at $38.04. Market cap is $4.32B. P/E ratio is 22.16. Revenue is $1.24B.
INDV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INDV recently traded at $38.04. Market cap is $4.32B. P/E ratio is 22.16. Revenue is $1.24B.
Is INDV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INDV. It does not provide personalized investment advice.
